Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: Data from the GISSI-AF trial

M Disertori; Maria Grazia Franzosi; Simona Barlera; Franco Cosmi; Silvia Quintarelli; Chiara Favero; Glauco Cappellini; Gianna Fabbri; Aldo Maggioni; Lidia Staszewsky; Luigi Andrea Moroni; Roberto Latini

doi:10.1186/1471-2261-13-28

Related publications

Article2020

Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study)

Andreas Goette, Professor Gregory Lip, James Jin, Hein Heidbüchel, Aron-Ariel Cohen, Michael D. Ezekowitz, José Luís Merino

Article2019

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry

Ying Wang, Changsheng Ma, Xin Du, Liu He, Jie Li, Guohong Wang, Dan Wen, Jianzeng Dong, Jianhong Pan, Professor Gregory Lip

Article2010

Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial

Roberto Latini, Serge Masson, Salvatore Pirelli, Simona Barlera, G. Pulitanò, Emanuele Carbonieri, Michele Massimo Gulizia, Tarcisio Vago, C. Favero, Dietmar Zdunek, Joachim Struck, Lidia Staszewsky, Aldo Maggioni, Maria Grazia Franzosi, M Disertori

Article2015

Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial

Lidia Staszewsky, Serge Masson, Simona Barlera, M Disertori, Silvana Boni, Daniele Bertoli, Olga Vriz, Elena Pasotti, Prisca Zeni, Tarcisio Vago, Aldo Maggioni, Gianni Tognoni, Roberto Latini

Article2008

Abstract 2120: Circulating Markers of Myocyte Injury Predict First Recurrence of Atrial Fibrillation. Data from the GISSI-Atrial Fibrillation Trial

Serge Masson, Salvatore Pirelli, G. Pulitanò, Emanuele Carbonieri, Michele Massimo Gulizia, Tarcisio Vago, Simona Barlera, Aldo Maggioni, Maria Grazia Franzosi, M Disertori, Roberto Latini